Skip to main content
Top
Published in: Medical Oncology 2/2012

01-06-2012 | Case Report

Unusual presentation of gastric plasmablastic lymphoma in HIV-negative patient

Authors: Biljana S. Mihaljevic, Milena R. Todorovic, Bosko M. Andjelic, Darko A. Antic, Maja D. Perunicic Jovanovic

Published in: Medical Oncology | Issue 2/2012

Login to get access

Abstract

Plasmablastic lymphoma (PBL) has initially been described as a rapidly progressive and almost invariably fatal diffuse large-cell lymphoma with plasmablastic features, exclusively involving the jaw and oral mucosa in HIV-positive patients. Although its clinical features may help in differential diagnosis, an extra-oral localization in a patient without HIV makes it more difficult to suspect clinically. We describe a very rare case of gastric PBL primarily involving stomach in a middle age man without an HIV infection. A biopsy was performed and its findings revealed a diffuse, monomorphous proliferation of the tumor cells with features of immunoblasts, MUM-1, EMA, and lambda light chains positive. Serology was negative for the human immunodeficiency virus (HIV), HBsAg, and hepatitis C virus infection. The patient started treatment with CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy, but unfortunately died before the second cycle was given. To our knowledge, this is the second case of gastric PBL presented in HIV-negative patients. The findings in this case suggest that PBL should be included in the differential diagnosis of gastrointestinal tumors.
Literature
1.
go back to reference Colomo L, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28:736–47.PubMedCrossRef Colomo L, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28:736–47.PubMedCrossRef
2.
go back to reference Stein H, Harris NL, Campo E. Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 256–7. Stein H, Harris NL, Campo E. Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 256–7.
3.
go back to reference Dong HY, et al. Plasmablastic lymphoma in HIV positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol. 2005;29:1633–41.PubMedCrossRef Dong HY, et al. Plasmablastic lymphoma in HIV positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol. 2005;29:1633–41.PubMedCrossRef
4.
go back to reference Delecluse HJ, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413–20.PubMed Delecluse HJ, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413–20.PubMed
5.
go back to reference Pruneri G, et al. Plasmablastic lymphoma of the stomach. A case report. Haematologica. 1998;83:87–9.PubMed Pruneri G, et al. Plasmablastic lymphoma of the stomach. A case report. Haematologica. 1998;83:87–9.PubMed
6.
go back to reference Lin Y, Rodrigues GD, Turner JF, Vasef MA. Plasmablastic lymphoma of the lung: report of a unique case and review of the literature. Arch Pathol Lab Med. 2001;125:282–5.PubMed Lin Y, Rodrigues GD, Turner JF, Vasef MA. Plasmablastic lymphoma of the lung: report of a unique case and review of the literature. Arch Pathol Lab Med. 2001;125:282–5.PubMed
7.
go back to reference Flaitz CM, Nichols CM, Walling DM, Hicks MJ. Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations. Oral Oncol. 2002;38:96–102.PubMedCrossRef Flaitz CM, Nichols CM, Walling DM, Hicks MJ. Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations. Oral Oncol. 2002;38:96–102.PubMedCrossRef
8.
go back to reference Onciu M, et al. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood. 2003;102:2642–4.PubMedCrossRef Onciu M, et al. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood. 2003;102:2642–4.PubMedCrossRef
9.
go back to reference Chetty R, Hlatswayo N, Muc R, Sabaratnam R, Gatter K. Plasmablastic lymphoma in HIV + patients: an expanding spectrum. Histopathology. 2003;42:605–9.PubMedCrossRef Chetty R, Hlatswayo N, Muc R, Sabaratnam R, Gatter K. Plasmablastic lymphoma in HIV + patients: an expanding spectrum. Histopathology. 2003;42:605–9.PubMedCrossRef
10.
go back to reference Nguyen DD, et al. Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol. 2003;82:521–5.PubMedCrossRef Nguyen DD, et al. Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol. 2003;82:521–5.PubMedCrossRef
11.
go back to reference Teruya-Feldstein J, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and HIV-negative patients. Ann Oncol. 2004;15:1673–9.PubMedCrossRef Teruya-Feldstein J, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and HIV-negative patients. Ann Oncol. 2004;15:1673–9.PubMedCrossRef
12.
go back to reference Vieira FO, et al. Plasmablastic lymphoma in a previously undiagnosed AIDS patient: a case report. Head Neck Pathol. 2008;2:92–6.PubMedCrossRef Vieira FO, et al. Plasmablastic lymphoma in a previously undiagnosed AIDS patient: a case report. Head Neck Pathol. 2008;2:92–6.PubMedCrossRef
13.
go back to reference Castillo JJ, et al. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. 2010;51:2047–53.PubMedCrossRef Castillo JJ, et al. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. 2010;51:2047–53.PubMedCrossRef
14.
go back to reference Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008;83:804–9.PubMedCrossRef Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008;83:804–9.PubMedCrossRef
15.
go back to reference Hatanaka K, Nakamura N, Kishimoto K, Sugino K, Uekusa T. Plasmablastic lymphoma of the cecum: Report of a case with cytologic findings. Diagn Cytopathol. 2010. [Epub ahead of print]. Hatanaka K, Nakamura N, Kishimoto K, Sugino K, Uekusa T. Plasmablastic lymphoma of the cecum: Report of a case with cytologic findings. Diagn Cytopathol. 2010. [Epub ahead of print].
16.
go back to reference Montes-Moreno S, et al. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica. 2010;95:1342–9.PubMedCrossRef Montes-Moreno S, et al. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica. 2010;95:1342–9.PubMedCrossRef
17.
go back to reference Cha JM, et al. A case report with plasmablastic lymphoma of the jejunum. J Korean Med Sci. 2010;25:496–500.PubMedCrossRef Cha JM, et al. A case report with plasmablastic lymphoma of the jejunum. J Korean Med Sci. 2010;25:496–500.PubMedCrossRef
18.
go back to reference Kim JE, et al. Human immunodeficiency virus-negative plasmablastic lymphoma in Korea. Leuk Lymphoma. 2009;50:582–7.PubMedCrossRef Kim JE, et al. Human immunodeficiency virus-negative plasmablastic lymphoma in Korea. Leuk Lymphoma. 2009;50:582–7.PubMedCrossRef
Metadata
Title
Unusual presentation of gastric plasmablastic lymphoma in HIV-negative patient
Authors
Biljana S. Mihaljevic
Milena R. Todorovic
Bosko M. Andjelic
Darko A. Antic
Maja D. Perunicic Jovanovic
Publication date
01-06-2012
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2012
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-9930-z

Other articles of this Issue 2/2012

Medical Oncology 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.